Seminars in Cancer Biology,
Год журнала:
2023,
Номер
92, С. 16 - 27
Опубликована: Март 24, 2023
Excess
body
weight
is
a
global
health
problem
due
to
sedentary
lifestyle
and
unhealthy
diet,
affecting
2
billion
population
worldwide.
Obesity
major
risk
factor
for
metabolic
diseases.
Notably,
the
of
obesity
largely
depends
on
distribution,
which
visceral
adipose
tissues
but
not
subcutaneous
fats
are
closely
associated
with
comorbidities,
including
type
diabetes,
non-alcoholic
fatty
liver
disease,
cardiovascular
disease
certain
types
cancer.
Latest
multi-omics
mechanistical
studies
reported
crucial
involvement
genetic
epigenetic
alterations,
adipokines
dysregulation,
immunity
changes,
imbalance
white
brown
tissues,
gut
microbial
dysbiosis
in
mediating
pathogenic
association
between
comorbidities.
In
this
review,
we
explore
epidemiology
excess
up-to-date
mechanism
how
lead
chronic
complications.
We
also
examine
utilization
fat
measurement
as
an
accurate
clinical
parameter
assessment
healthy
individuals
outcome
prediction
obese
subjects.
addition,
current
approaches
prevention
treatment
its
related
comorbidities
further
discussed.
Frontiers in Cellular and Infection Microbiology,
Год журнала:
2020,
Номер
9
Опубликована: Янв. 15, 2020
Probiotics
have
been
used
to
treat
a
variety
of
diseases
for
decades:
however,
what
is
the
rationale
under
this?
Such
treatment
was
first
proposed
in
early
19th
century
based
on
observations
decreased
Bifidobacteria
populations
children
suffering
diarrhea,
suggesting
that
oral
intake
could
replete
microbiota
subpopulation
and
improve
health.
Since
then,
studies
shown
modifications
gut
or
skin
course
suggested
positive
effects
certain
probiotics.
Most
failed
report
any
impact
microbiota.
The
probiotics,
as
well
bacteria
colonizing
food,
does
not
reside
their
ability
graft
but
rather
sharing
genes
metabolites,
supporting
challenged
microbiota,
by
direct
influence
epithelial
immune
cells.
argue
probiotics
be
associated
conventional
drugs
insulin
resistance,
infectious
diseases,
inflammatory
psychiatric
disorders
also
interfere
with
drug
metabolism.
Nevertheless,
context
plethora
probiotic
strains
associations,
produced
such
conditions
do
allow
comparisons,
it
remains
difficult
know
whether
patient
would
benefit
from
taking
particular
probiotic.
In
other
words,
although
several
mechanisms
are
observed
when
studying
single
strain,
all
individual
expected
share
same
effects.
order
clarify
role
clinics,
we
explore
here
relation
between
World Journal of Gastroenterology,
Год журнала:
2021,
Номер
27(25), С. 3837 - 3850
Опубликована: Июль 5, 2021
Obesity
is
a
major
global
health
problem
determined
by
heredity
and
environment,
its
incidence
increasing
yearly.
In
recent
years,
evidence
linking
obesity
to
the
gut
microbiota
has
been
reported.
Gut
management
become
new
method
of
treatment.
However,
complex
interactions
among
genetics,
microbiota,
remain
poorly
understood.
this
review,
we
summarize
characteristics
in
obesity,
mechanism
induced
influence
genetic
environmental
factors
on
provide
support
for
understanding
relationship
between
microbiota.
At
same
time,
prospect
research
related
proposed.
Molecular and Cellular Endocrinology,
Год журнала:
2022,
Номер
546, С. 111572 - 111572
Опубликована: Янв. 20, 2022
The
role
of
the
intestinal
microbiota
as
a
regulator
gut-brain
axis
signalling
has
risen
to
prominence
in
recent
years.
Understanding
relationship
between
gut
microbiota,
metabolites
it
produces,
and
brain
will
be
critical
for
subsequent
development
new
therapeutic
approaches,
including
identification
novel
psychobiotics.
A
key
focus
this
regard
have
been
short-chain
fatty
acids
(SCFAs)
produced
by
bacterial
fermentation
dietary
fibre,
which
include
butyrate,
acetate,
propionate.
Ongoing
research
is
focused
on
entry
SCFAs
into
systemic
circulation
from
lumen,
their
migration
cerebral
across
blood
barrier,
potential
exert
acute
chronic
effects
structure
function.
This
review
aims
discuss
our
current
mechanistic
understanding
direct
indirect
influence
that
function,
behaviour
physiology,
inform
future
microbiota-targeted
interventions
disorders.
Nature Communications,
Год журнала:
2020,
Номер
11(1)
Опубликована: Окт. 6, 2020
Abstract
Human
gut
microbiome
is
a
promising
target
for
managing
type
2
diabetes
(T2D).
Measures
altering
microbiota
like
oral
intake
of
probiotics
or
berberine
(BBR),
bacteriostatic
agent,
merit
metabolic
homoeostasis.
We
hence
conducted
randomized,
double-blind,
placebo-controlled
trial
with
newly
diagnosed
T2D
patients
from
20
centres
in
China.
Four-hundred-nine
eligible
participants
were
enroled,
randomly
assigned
(1:1:1:1)
and
completed
12-week
treatment
either
BBR-alone,
probiotics+BBR,
probiotics-alone,
placebo,
after
one-week
run-in
gentamycin
pretreatment.
The
changes
glycated
haemoglobin,
as
the
primary
outcome,
probiotics+BBR
(least-squares
mean
[95%
CI],
−1.04[−1.19,
−0.89]%)
BBR-alone
group
(−0.99[−1.16,
−0.83]%)
significantly
greater
than
that
placebo
probiotics-alone
groups
(−0.59[−0.75,
−0.44]%,
−0.53[−0.68,
−0.37]%,
P
<
0.001).
BBR
induced
more
gastrointestinal
side
effects.
Further
metagenomics
metabolomic
studies
found
hypoglycaemic
effect
mediated
by
inhibition
DCA
biotransformation
Ruminococcus
bromii
.
Therefore,
our
study
reports
human
microbial
related
mechanism
underlying
antidiabetic
on
T2D.
(Clinicaltrial.gov
Identifier:
NCT02861261).
Aging and Disease,
Год журнала:
2022,
Номер
13(4), С. 1106 - 1106
Опубликована: Янв. 1, 2022
Gut
microbiota,
a
collection
of
microorganisms
that
live
within
gastrointestinal
tract,
provides
crucial
signaling
metabolites
for
the
physiological
hosts.
In
healthy
state,
gut
microbiota
are
helpful
maintaining
basic
functions
hosts,
whereas
disturbed
production
these
can
lead
to
numerous
diseases
such
as
metabolic
diseases,
cardiovascular
neurodegenerative
and
cancer.
Although
there
many
reviews
about
specific
mechanisms
on
is
no
comprehensive
summarization
metabolites.
this
Opinion,
we
discuss
knowledge
including
types
their
ways
acting
targets.
addition,
summarize
pathologic
in
health
shaping
composition
nutrition.
This
paper
be
understanding
roles
thus
provide
guidance
developing
suitable
therapeutic
strategies
combat
microbial-driven
improve
health.
Frontiers in Nutrition,
Год журнала:
2019,
Номер
6
Опубликована: Дек. 20, 2019
Metabolic
diseases
can
change
the
gut
microbiota
composition
and
function,
pathogenic
bacteria
contribute
to
development
of
metabolic
disorders.
Polyphenols
may
act
in
favor
increase
beneficial
hamper
bacteria.
In
addition,
on
polyphenols
their
bioavailability.
This
two-way
interaction
between
could
affect
human
metabolism
reduce
cardiometabolic
risk.
Despite
possible
benefits
for
health
through
modulating
microbiome,
studies
are
scarce
present
several
limitations.
review
provides
an
overview
polyphenol–microbiota
its
effects
Reviews in Endocrine and Metabolic Disorders,
Год журнала:
2019,
Номер
20(4), С. 439 - 447
Опубликована: Окт. 25, 2019
Abstract
There
is
now
a
wealth
of
evidence
showing
that
communication
between
microbiota
and
the
host
critical
to
sustain
vital
functions
healthy
host,
disruptions
this
homeostatic
coexistence
are
known
be
associated
with
range
diseases
including
obesity
type
2
diabetes.
Microbiota-derived
metabolites
act
both
as
nutrients
messenger
molecules
can
signal
distant
organs
in
body
shape
pathophysiology.
In
review,
we
provide
new
perspective
on
succinate
gut
microbiota-derived
metabolite
key
role
governing
intestinal
homeostasis
energy
metabolism.
Thus,
not
merely
major
intermediary
TCA
traditionally
considered
an
extracellular
danger
but
also
by-product
some
bacteria
primary
cross-feeding
resident
microbes.
addition
maintain
microbiome,
specific
peripheral
tissues
regulating
nutrient
metabolism
should
rule
out.
Indeed,
recent
research
point
probiotic
interventions
directed
modulate
levels
lumen,
microbiota-based
therapies
treat
related
co-morbidities.
While
further
essential,
large
strategic
mediator
microbiota-host
cross-talk,
which
might
basis
for
therapeutically
approaches
near
future.